CCCC vs LDOS · rev $35.6M vs P/E 16, rev $16.66B
C4 Therapeutics Inc (CCCC) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
CCCC currently screens at market cap $425.7M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the CCCC and LDOS stock pages for the full models.
Not investment advice.